These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 4933354)

  • 21. Axonal degeneration in experimental diphtheritic polyneuritis.
    Brown WF; Gilbert JG
    Trans Am Neurol Assoc; 1974; 99():62-6. PubMed ID: 4463564
    [No Abstract]   [Full Text] [Related]  

  • 22. Axonal conduction and injury in multiple sclerosis: the role of sodium channels.
    Waxman SG
    Nat Rev Neurosci; 2006 Dec; 7(12):932-41. PubMed ID: 17115075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment for multiple sclerosis.
    Davis FA; Schauf CL; Michael JA; Becker FO
    N Engl J Med; 1973 May; 288(21):1128. PubMed ID: 4633305
    [No Abstract]   [Full Text] [Related]  

  • 24. Thermal sensitivity in demyelinating neuropathy.
    Chaudhry V; Crawford TO; DeRossett SE
    Muscle Nerve; 1993 Mar; 16(3):301-6. PubMed ID: 8446129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visual evoked potentials in demyelinating disease.
    Halliday AM
    Adv Neurol; 1981; 31():201-15. PubMed ID: 7325043
    [No Abstract]   [Full Text] [Related]  

  • 26. Features of central and peripheral nerve conduction in demyelinating diseases and specific neuropathies in Japan.
    Shibasaki H; Ohnishi A; Kuroiwa Y
    Electroencephalogr Clin Neurophysiol Suppl; 1982; 36():111-25. PubMed ID: 6962008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Physiopathology of the clinical manifestation of multiple sclerosis. Electrophysiological hypotheses].
    Cesaro P; Degos JD; Martin-Mondière C
    Rev Neurol (Paris); 1984; 140(1):20-7. PubMed ID: 6364291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In response to "Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies".
    Caliandro P; Stålberg E; Padua L
    Clin Neurophysiol; 2008 Jul; 119(7):1694-5. PubMed ID: 18467169
    [No Abstract]   [Full Text] [Related]  

  • 29. Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies.
    Tankisi H; Pugdahl K; Johnsen B; Fuglsang-Frederiksen A
    Clin Neurophysiol; 2007 Nov; 118(11):2383-92. PubMed ID: 17900975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temperature change and multiple sclerosis.
    McDonald WI; Sears TA
    Br Med J; 1972 Dec; 4(5843):794. PubMed ID: 4646529
    [No Abstract]   [Full Text] [Related]  

  • 31. Experimental strategies to promote central nervous system remyelination in multiple sclerosis: insights gained from the Theiler's virus model system.
    Miller DJ; Asakura K; Rodriguez M
    J Neurosci Res; 1995 Jun; 41(3):291-6. PubMed ID: 7563222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanisms of lability of neurological symptoms in multiple sclerosis].
    Peresedova AV; Baĭdina EV; Trifonova OV; Aĭzenberg IV; Gnezditskiĭ VV; Barkhatova VP; Chernikova LA; Zavalishin IA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; Suppl():15-9. PubMed ID: 12418387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of temperature on conduction in demyelinated single nerve fibers.
    Rasminsky M
    Arch Neurol; 1973 May; 28(5):287-92. PubMed ID: 4696011
    [No Abstract]   [Full Text] [Related]  

  • 34. [Medullar and supraspinal conduction in multiple sclerosis: localization value (author's transl)].
    Obeso JA; Marti Massó JF; Carrera N
    Med Clin (Barc); 1980 Mar; 74(5):183-7. PubMed ID: 7382611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overcoming conduction failure in demyelinated nerve fibres by prolonging action potentials.
    Bostock H; Sherratt RM; Sears TA
    Nature; 1978 Jul; 274(5669):385-7. PubMed ID: 209331
    [No Abstract]   [Full Text] [Related]  

  • 36. Bibliography. Current world literature. Demyelinating diseases.
    Curr Opin Neurol; 2006 Jun; 19(3):316-28. PubMed ID: 16702842
    [No Abstract]   [Full Text] [Related]  

  • 37. Enhancement of action potential conduction following demyelination: experimental approaches to restoration of function in multiple sclerosis and spinal cord injury.
    Waxman SG; Utzschneider DA; Kocsis JD
    Prog Brain Res; 1994; 100():233-43. PubMed ID: 7938524
    [No Abstract]   [Full Text] [Related]  

  • 38. Etiologic correlations between idiopathic polyneuritis and multiple sclerosis: therapeutic implications.
    Arnason BG; Mantos JJ
    Mod Treat; 1970 Sep; 7(5):903-17. PubMed ID: 4326376
    [No Abstract]   [Full Text] [Related]  

  • 39. Central motor pathway conduction in multiple sclerosis.
    Matthews WB
    Lancet; 1984 Sep; 2(8401):518. PubMed ID: 6147573
    [No Abstract]   [Full Text] [Related]  

  • 40. Differential changes in axonal conduction following CNS demyelination in two mouse models.
    Bando Y; Takakusaki K; Ito S; Terayama R; Kashiwayanagi M; Yoshida S
    Eur J Neurosci; 2008 Nov; 28(9):1731-42. PubMed ID: 18973589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.